Comparative Colloidal Stability of Commercial Amphotericin B Nanoformulations Using Dynamic and Static Multiple Light Scattering Techniques [Corrigendum]

Abstract

Ye J, Li R, Cheng J, et al. Int J Nanomedicine. 2022;17:6047–6064. The authors have advised that there is an error in Figure 9 on page 6060 of the published paper. Due to an error that occurred inadvertently at the time of figure assembly, figure part D is incorrect. Although it does not affect the conclusion that AmB nanoformulations can significantly promote macrophage proliferation when incubated with high concentrations, it is an obvious mistake. The correct Figure 9 is as follows. Figure 9 Continued. Figure 9 In vitro cytotoxicity of AmB injection, AmB-CSC, and AmB-Lipo in murine RAW264.7 macrophages. The murine RAW264.7 macrophages were treated with AmB injection (A), AmB-CSC (C), and AmB-Lipo (E) at AmB concentrations of 0.1–50 µg/mL for 24 h and the cell viability was determined using CCK-8 kits. Each value represents the mean ± SEM (n = 6). ***p < 0.001 compared with the control (Ctrl) group. The cell morphology of RAW264.7 macrophages after incubation with AmB injection (B), AmB-CSC (D), and AmB-Lipo (F) was observed by Cell Imaging Multimode Reader (Cytation 5, BioTek).Abbreviations: AmB, amphotericin B; AmB-CSC, AmB cholesteryl sulfate complex; AmB-Lipo, AmB liposome; SEM, standard error of the mean. The authors apologise for this error.

Keywords

• nano-drug delivery systems
• colloidal stability
• amphotericin b
• dynamic light scattering
• static multiple light scattering